Talk:Ertapenem
Appearance
This is the talk page for discussing improvements to the Ertapenem article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ertapenem.
|
A fact from Ertapenem appeared on Wikipedia's Main Page in the Did you know column on 15 August 2020 (check views). The text of the entry was as follows:
|
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
The IUPAC name is lacking stereochemistry specifics.--ChemSpiderMan (talk) 02:17, 17 December 2007 (UTC)
- I switched to the IUPAC name given at the PubChem link which has stereochemistry. -- Ed (Edgar181) 15:27, 18 December 2007 (UTC)
- I was going to do that when I redrew the structure, but completely forgot :) Thanks, Ed. Fvasconcellos (t·c) 00:13, 19 December 2007 (UTC)
IUPAC NAme and Structure
[edit]I think the correct IUPAC Name is
(4R,5S,6S)-3-({(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
and the structure as drawn is incorrect--ChemSpiderMan (talk) 23:05, 18 May 2008 (UTC)
15 years
[edit]The marketing slogan has been on this page for 15 years, since it was created in 2003. ARGH. Jytdog (talk) 04:04, 4 May 2018 (UTC)
Did you know nomination
[edit]- The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.
The result was: promoted by Cwmhiraeth (talk) 06:37, 10 August 2020 (UTC)
( )
- ... that the antibiotic ertapenem can dramatically reduce the concentrations of an anti-seizure drug in the blood plasma? Source: https://pubmed.ncbi.nlm.nih.gov/27322166/ "Ertapenem and meropenem had a greater effect on VPA serum concentration than imipenem/cilastatin. Because of the dramatic reduction of VPA serum concentration during CBPMs' use, concomitant use of VPA and CBPMs should be avoided."
- Reviewed: Umbrella slug
5x expanded by Anypodetos (talk). Self-nominated at 13:27, 30 July 2020 (UTC).
- - 5x expansion less than 7 days before nomination. Article is not a stub any more and well over 1500 characters. Copyvio check reveals no similar text. Fact is sourced (I've added two extra sources on a related topic.) Although I am not a subject-matter expert no problems showing up. Hook formatting is OK, length less than 200 characters. Seems good to go.